Around 10% of the global population is affected by chronic kidney disease (CKD) and over 2 million people suffer from end-stage renal disease (ESRD), which has to be treated by dialysis or kidney transplant. Health care spending on kidney in general and specifically on ESRD is on a rise. In 2014, overall Medicare spending on the treatment of ESRD was over US$ 32 Bn, while the National Health Service (NHS) spends around 3% of its budget on kidney failure services. The burden of kidney diseases is rising in developing countries as well, with nearly half a million patients in China undergoing dialysis (Source: National Kidney Foundation, Center for Medicare and Medicaid Services, NHS).
Rise in prevalence of ESRD is driven by increase in prevalence of diabetes and geriatric population. According to the International Diabetes Federation, globally, the number of adults with diabetes (diagnosed or undiagnosed) is projected to increase from 415 million in 2016 to 642 million by 2040, while people aged 60 years and above are expected to account for 17% of the global population by 2030, up from 12% presently (Source: WHO and International Diabetes Federation).
Based on type of services, the global dialysis centers market can be classified into in-center dialysis, in-center nocturnal dialysis, home hemodialysis, peritoneal dialysis, and other services such as disease management and emergency services. Home dialysis offers benefits such as better outcome and higher level of flexibility over in-center dialysis. However, global statistics indicate that over 85% of the patients prefer in-center dialysis even when health care professionals believe that home dialysis could be a better option for ESRD patients. Preference for home dialysis is lower in the U.S., with over 93% of patients choosing in-center hemodialysis.
In terms of region, the global dialysis centers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presently, majority of the dialysis centers are located in developed economies such as the U.S., Germany, Japan, Italy, and the U.K. More than 2,200 of the 3,600 dialysis centers operated by Fresenius Medical Care are located in the U.S. In India, less than 30% of the ESRD patients undergo dialysis due to factors such as high cost and lack of access to dialysis centers. Moreover, developing economies such as India and China are expected to present significant opportunities in the market due to rise in affordability among the population and government initiatives to improve access to dialysis services. Nephroplus, the largest chain of dialysis centers in India, plans to use the US$ 15 Mn raised through Series-C funding in 2016 to expand from 100 centers to 500 centers in five years.
Key players in the global dialysis centers market are Fresenius Kidney Care, DaVita, Inc., U.S. Renal Care, Inc., Diaverum, NephroCare (part of Fresenius Medical Care), B. Braun Melsungen AG, Yueda Group, NephroPlus, Apex Kidney Care, Deep Chand Dialysis Center, and Kaikoukai Healthcare Group, among others. The market is expected to continue to consolidate, as larger players such as Fresenius and DaVita acquire smaller companies to reduce price competition and increase market share. In May 2018, DaVita acquired ten dialysis centers of Purity Dialysis, a player based in the U.S.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.